IP Library Granted Patent US 7,785,825
Granted Patent B2
US 7,785,825 · App. 11/034,275 · Granted Aug 31, 2010

Compositions and methods for dehydration and cyclization of peptides, synthetic compounds, and lantibiotics

Assignee: The Board of Trustees of the University of Illinois
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,785,825
App. No.
11/034,275
Granted
Aug 31, 2010
Kind
B2
Abstract

Lantibiotics are synthesized on ribosomes as prepeptides and post-translationally modified to a mature form. These modifications include dehydrations and cyclizations. Compounds and related methods of generating compounds, modified by dehydration, cyclization, or dehydration and cyclization, are disclosed. The disclosure includes in vitro approaches to effecting dehydration and cyclization leading to production of biologically active compounds such as lantibiotics and variants thereof. Synthetic variants and methods including combinatorial approaches for generating diverse lantibiotics and other compounds are disclosed. The invention has broad potential for applications including food, agricultural, and medical industries.

Claims (28)

1. A method of modifying a lantibiotic precursor peptide by dehydration or dehydration and cyclization, comprising:

(a) providing said lantibiotic precursor peptide;

(b) providing a purified LctM enzyme capable of catalyzing dehydration and cyclization of the lantibiotic precursor peptide, wherein said LctM enzyme has at least 95% sequence identity to SEQ ID NO:40 and enzymatic activity of dehydration or dehydration and cyclization of the lantibiotic precursor peptide of SEQ ID NO:3; and

(c) incubating a reaction mixture comprising a divalent metal cation, ATP, said lantibiotic precursor peptide of (a) and said LctM enzyme; thereby modifying said lantibiotic precursor peptide by dehydration or dehydration and cyclization.

2. The method of claim 1 , wherein the lantibiotic precursor peptide comprises at least one non-proteinogenic amino acid, unnatural amino acid, beta amino acid, peptoid, or derivatized amino acid.

3. The method of claim 1 , wherein the reaction mixture further comprises magnesium.

4. The method of claim 1 , wherein the reaction mixture further comprises magnesium and zinc.

5. The method of claim 1 , wherein the reaction mixture further comprises magnesium, zinc, and DTT.

6. A method of generating a biologically active lantibiotic compound, comprising:

(a) incubating a reaction mixture comprising a divalent metal ion, ATP, a lantibiotic precursor peptide and a purified LctM enzyme having at least 95% identity to SEQ ID NO:40 and enzymatic activity of dehydration or dehydration and cyclization of the lantibiotic precursor peptide of SEQ ID NO: 3; and

(b) cleaving a leader portion of the lantibiotic precursor peptide; thereby generating said biologically active lantibiotic compound.

7. The method of claim 6 , wherein said divalent metal cation is zinc or magnesium.

8. A method of modifying a lantibiotic precursor peptide by dehydration or dehydration and cyclization, comprising:

(a) providing said lantibiotic precursor peptide;

(b) providing a purified LctM enzyme capable of catalyzing dehydration and cyclization of the lantibiotic precursor peptide, wherein said LctM enzyme comprises the amino acid sequence as set forth in SEQ ID NO:40; and

(c) incubating a reaction mixture comprising a divalent metal cation, ATP, said lantibiotic precursor peptide of (a) and said LctM enzyme; thereby modifying said lantibiotic precursor peptide by dehydration or dehydration and cyclization.

9. The method of claim 8 , wherein said LctM enzyme consists of the sequence set forth in SEQ ID NO:40.

10. The method of claim 9 wherein said divalent metal cation is zinc or magnesium.

11. The method of claim 9 wherein the reaction mixture further comprises DTT.

12. The method of claim 9 , wherein the reaction mixture further comprises DTT.

13. A method of generating a biologically active lantibiotic compound, comprising:

(a) incubating a reaction mixture comprising a divalent metal ion, ATP, a lantibiotic precursor peptide and a purified LctM enzyme comprising the amino acid sequence as set forth in SEQ ID NO: 40; and

(b) cleaving a leader portion of the lantibiotic precursor peptide; thereby generating said biologically active lantibiotic compound.

14. The method of claim 13 , wherein said LctM enzyme consists of the sequence set forth in SEQ ID NO:40.

15. The method of claim 13 , wherein the lantibiotic precursor peptide comprises at least one non-proteinogenic amino acid, unnatural amino acid, beta amino acid, peptoid, or derivatized amino acid.

16. The method of claim 13 , wherein said divalent metal cation is zinc or magnesium.

17. The method of claim 13 , wherein said reaction mixture further comprises DTT.

18. The method of claim 9 , wherein the lantibiotic precursor peptide comprises at least one non-proteinogenic amino acid, unnatural amino acid, beta amino acid, peptoid, or derivatized amino acid.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 7, 2011
From: UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025750/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2005
From: VAN DER DONK, WILLEM A.; XIE, LILI; CHATTERJEE, CHAMPAK; PAUL, MOUSHUMI
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 015816/0183 →
Continuity (2)
Provisional Application 6053614000 · Jan 12, 2004
Related Publication 20050164339A1 · Jul 28, 2005